Gilenya Approved for Relapsing MS - Drugs.com MedNews
Links shared publicly online about this topic.
- 855total visits
Gilenya Approved for Relapsing MS - Drugs.com MedNews
View full resource at drugs.com
Tags: Drug, Disability, FDA
Most Recently Shared on September 22, 2010 at 5:12 pm By:
Gilenya Approved for Relapsing MS: WEDNESDAY, Sept. 22 -- Gilenya (fingolimod) has been approved by the U.S. ... http://bit.ly/cIkSwX #drug
Biogen Idec Receives Approval In The European Union For AVONEX(R) PEN™
medicalnewstoday.com — “Biogen Idec (NASDAQ: BIIB) announced today that the European Commission (EC) has granted approval to AVONEX PEN for patients with relapsing multiple sclerosis (MS) and patients who have had a sing” View full resource at medicalnewstoday.com
Most Recently Shared on June 7, 2011 at 12:06 pm By:
Biogen Idec Receives Approval In The European Union For AVONEX(R) PEN™ http://mnt.to/3WRt #multiplesclerosis
Multiple Sclerosis Oral Treatment Approved in Canada
disabled-world.com — “Gilenya (fingolimod) is the first disease modifying oral therapy developed for the relapsing-remitting form of multiple sclerosis (MS)” View full resource at disabled-world.com
Most Recently Shared on March 10, 2011 at 2:50 pm By:
Disabled World Health Advocate and Health News
Multiple Sclerosis Oral Treatment Approved in Canada http://ff.im/-zovzM
Imaging against multiple sclerosis: Iodinated radiotracer candidate for PET and SPECT imaging
physorg.com — “(PhysOrg.com) -- A first-line treatment for relapsing forms of multiple sclerosis (MS) was approved in September 2010 by the US Food and Drug Administration: FTY720 (fingolimod, Gilenya), which acts as a sphingosine 1-phosphate (S1P) receptor modulator.” View full resource at physorg.com
Most Recently Shared on February 4, 2011 at 7:03 pm By:
Imaging against multiple sclerosis: Iodinated radiotracer candidate for PET and SPECT imaging: (PhysOrg.com) -- ... http://bit.ly/ecouE5
FDA Approves First Oral Drug To Reduce MS Relapses
medicalnewstoday.com — “The U.S. Food and Drug Administration has approved Gilenya capsules (fingolimod) to reduce relapses and delay disability progression in patients with relapsing forms of multiple sclerosis (MS).” View full resource at medicalnewstoday.com
Most Recently Shared on September 24, 2010 at 11:05 pm By:
MNT Drug Approvals Health News
FDA Approves First Oral Drug To Reduce MS Relapses http://mnt.to/3Khy #regulatory
FDA Approves Breakthrough Pill to Treat Multiple Sclerosis - Patient Power
patientpower.info — “The first-ever oral therapy to treat relapsing-remitting multiple sclerosis has been approved by the FDA. University of Washington neurologist and MS specialist, Dr. Sylvia Lucas, explains what it means and gives guidance for patients.” View full resource at patientpower.info
Most Recently Shared on September 24, 2010 at 8:22 pm By:
Our Breaking News interview with Dr. Sylvia Lucas: FDA Approves Breakthrough Pill to Treat #MS #Gilenya - Patient Power http://t.co/lco3wo2
FDA Approves First Oral Drug To Reduce MS Relapses
medicalnewstoday.com — “The U.S. Food and Drug Administration has approved Gilenya capsules (fingolimod) to reduce relapses and delay disability progression in patients with relapsing forms of multiple sclerosis (MS).” View full resource at medicalnewstoday.com
Most Recently Shared on September 23, 2010 at 2:37 pm By:
FDA Approves First Oral Drug To Reduce MS Relapses: The U.S. Food and Drug Administration has approved Gilenya cap... http://mnt.to/f/3Kdv
F.D.A. Approves Novartis's Gilenya, a Treatment for M.S. - NYTimes.com
nytimes.com — “Agency backing had largely been expected after a unanimous recommendation by an advisory panel in June for the treatment of relapsing multiple sclerosis.” View full resource at nytimes.com
Most Recently Shared on September 23, 2010 at 12:55 pm By:
F.D.A. Approves Novartis’s Gilenya, a Treatment for M.S. - http://nyti.ms/apPRPp
Gilenya Approved for Relapsing MS --Doctors Lounge
doctorslounge.com — “Gilenya Approved for Relapsing MS --Doctors Lounge” View full resource at doctorslounge.com
Most Recently Shared on September 22, 2010 at 11:53 pm By:
Gilenya Approved for Relapsing MS: Oral drug designed to slow progressive disability http://bit.ly/cikQYP
F.D.A. Approves Novartis's Gilenya, a Treatment for M.S. - NYTimes.com
nytimes.com — “Agency backing had largely been expected after a unanimous recommendation by an advisory panel in June for the treatment of relapsing multiple sclerosis.” View full resource at nytimes.com
Most Recently Shared on September 22, 2010 at 11:11 pm By:
Pill to Treat Multiple Sclerosis Receives Approval of F.D.A. http://nyti.ms/adAQS4
F.D.A. Approves Novartis's Gilenya, a Treatment for M.S. - NYTimes.com
nytimes.com — “Agency backing had largely been expected after a unanimous recommendation by an advisory panel in June for the treatment of relapsing multiple sclerosis.” View full resource at nytimes.com
Most Recently Shared on September 22, 2010 at 10:54 pm By:
Pill to Treat Multiple Sclerosis Receives Approval of F.D.A.: Agency backing had largely been expected after a una... http://bit.ly/9rjZeO
Oral Drug to Reduce MS Relapses FDA Approved
disabled-world.com — “FDA has approved Gilenya capsules (fingolimod) to reduce relapses and delay disability progression in patients with relapsing forms of multiple sclerosis (MS)” View full resource at disabled-world.com
Most Recently Shared on September 22, 2010 at 8:04 pm By:
Disabled World Health Advocate and Health News
Oral Drug to Reduce MS Relapses FDA Approved http://ff.im/-qXZCQ
Multiple Sclerosis Drug Gilenya (Fingolimod) Approved By FDA - QualityPoint Technologies
qualitypointtech.net — “Gilenya (fingolimod) 0.5 mg daily for the treatment of relapsing forms of multiple sclerosis has been approved by the Food and Drug Administration. Swiss pharmaceutical company, Novartis, says that Gilenya is the first oral medication indicated for relapsing forms of multiple sclerosis (MS) in the United States - it reduces the frequency of MS flare-up, as well as helping slow down the build-up of some of the physical problems associated with MS. Clinical trials involving 2,600 patients demonstr” View full resource at qualitypointtech.net
Most Recently Shared on September 22, 2010 at 7:12 pm By:
Multiple Sclerosis Drug Gilenya (Fingolimod) Approved By FDA: Gilenya (fingolimod) 0.5 mg daily for the treatment ... http://bit.ly/dxL7QD
Fingolimod Receives FDA Approval as First Oral MS Treatment - QualityPoint Technologies
qualitypointtech.net — “The FDA has approved the drug, which will be marketed by Novartis as Gilenya, to reduce relapses and reduce progression of disability in patients with relapsing-remitting MS. Medscape Medical News” View full resource at qualitypointtech.net
Most Recently Shared on September 22, 2010 at 6:48 pm By:
Fingolimod Receives FDA Approval as First Oral MS Treatment: The FDA has approved the drug, which will be marketed... http://bit.ly/baYCDR
FDA approves Gilenya capsules for reducing MS relapses
news-medical.net — “The U.S. Food and Drug Administration has approved Gilenya capsules (fingolimod) to reduce relapses and delay disability progression in patients with relapsing forms of multiple sclerosis (MS).” View full resource at news-medical.net
Most Recently Shared on September 22, 2010 at 1:40 pm By:
FDA approves Gilenya capsules for reducing MS relapses: The U.S. Food and Drug Administration has approved Gilenya... http://bit.ly/cOWC1h
F.D.A. Approves Novartis's Gilenya, a Treatment for M.S. - NYTimes.com
nytimes.com — “Agency backing had largely been expected after a unanimous recommendation by an advisory panel in June for the treatment of relapsing multiple sclerosis.” View full resource at nytimes.com
Most Recently Shared on September 22, 2010 at 1:15 pm By:
Oral Treatment for MS Receives FDA Approval http://bit.ly/aBlHEW
Advertisement
